Vaccines

Health By Jason Mast

CDC recommends Pfizer, Moderna Covid vaccines for children under 5

Pharmalot By Ed Silverman

WTO reaches a deal on Covid vaccine patent waivers, but industry and advocates remain unhappy

Health By Matthew Herper

FDA authorizes Pfizer and Moderna Covid vaccines for infants, toddlers, and preschoolers

The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: Paul Offit on Covid vaccines for kids, plus: how the Fed affects biotech, & another Alzheimer’s setback

First Opinion By Steve Brozak and Richard Marfuggi

Lessons from earlier pandemics: Vaccine panel must discuss imprinting among infants and toddlers

Pharmalot By Ed Silverman

Pharmalittle: Canada OKs ALS drug still waiting FDA approval; WTO talks on Covid patent waiver are down to the wire

First Opinion By Thomas B. Cueni

Waiving intellectual property rights is a flawed solution to achieving Covid-19 vaccine equity

Pharmalot By Ed Silverman

Pharmalittle: FDA panel endorses Bluebird Bio gene therapy for rare disease; GSK touts RSV vaccine trial results

Politics By Rachel Cohrs

How the Covid-19 pandemic prepared the White House to respond to monkeypox

First Opinion By Muhammad Yunus

Preparing for the next pandemic: Time to follow a social business model for patent-free global medicine production

The Readout LOUD By Adam Feuerstein and Meg Tirrell

Listen: Covid vaccines for the youngest kids, ASCO preview, & a biotech CEO’s arrest on murder charges

Health By Helen Branswell

Pfizer/BioNTech to seek Covid vaccine authorization for children under age 5

Pharmalot By Ed Silverman

Pharmalittle: Cancer coalition aims to boost access to meds in poor countries; Moderna’s vaccine patent defense poses shield for others

Health By Matthew Herper

CDC recommends Covid boosters for kids ages 5 to 11 after advisory committee vote

Health By Elizabeth Cooney

Large U.K. study links vaccination after Covid infection to lower odds of long Covid symptoms

Health By Lauran Neergaard — Associated Press

FDA clears Covid booster shot for healthy kids ages 5 to 11

Health By Rachel Cohrs

What happens when the government stops buying Covid-19 vaccines?

Pharmalot By Ed Silverman

National Institutes of Health licenses nearly a dozen Covid-19 technologies to a WHO program

Politics By Lev Facher

Dr. Oz peddles medical misinformation — but could his political rise have a silver lining for public health?

Pharmalot By Ed Silverman

Why a controversial patent rights waiver could be a ‘missed opportunity’ to tackle the next pandemic

Health By Alex Hogan

Watch: A STAT reporter’s race to keep up with Covid-19

First Opinion By Nina Schwalbe

Strengthening Gavi is a way forward for global vaccine equity

Exclusive By Rachel Cohrs

White House documents detail a looming squeeze on Covid-19 boosters

Pharmalot By Ed Silverman

A compromise on patent waivers for Covid-19 vaccines takes a key step at the WTO

First Opinion By Els Torreele

Global health should not be determined by pharma investors and shareholders